Envestnet Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.14M | Sell |
21,998
-3,309
| -13% | -$169K | ﹤0.01% | 3389 |
|
|
2025
Q4 | $1.26M | Sell |
25,307
-1,705
| -6% | -$82.9K | ﹤0.01% | 3140 |
|
|
2025
Q3 | $1.29M | Sell |
27,012
-63,513
| -70% | -$2.56M | ﹤0.01% | 3186 |
|
|
2025
Q2 | $2.85M | Buy |
90,525
+30,256
| +50% | +$970K | ﹤0.01% | 2571 |
|
|
2025
Q1 | $1.97M | Buy |
60,269
+299
| +0.5% | +$10.6K | ﹤0.01% | 2741 |
|
|
2024
Q4 | $2.17M | Buy |
59,970
+3,495
| +6% | +$123K | ﹤0.01% | 2643 |
|
|
2024
Q3 | $1.76M | Sell |
56,475
-2,660
| -4% | -$83K | ﹤0.01% | 2751 |
|
|
2024
Q2 | $1.58M | Sell |
59,135
-29,213
| -33% | -$847K | ﹤0.01% | 2740 |
|
|
2024
Q1 | $3.01M | Buy |
88,348
+12,604
| +17% | +$375K | ﹤0.01% | 2319 |
|
|
2023
Q4 | $2.19M | Sell |
75,744
-3,784
| -5% | -$100K | ﹤0.01% | 2412 |
|
|
2023
Q3 | $2.19M | Sell |
79,528
-4,078
| -5% | -$124K | ﹤0.01% | 2334 |
|
|
2023
Q2 | $2.51M | Sell |
83,606
-372,809
| -82% | -$13M | ﹤0.01% | 2143 |
|
|
2023
Q1 | $2.56M | Buy |
456,415
+369,806
| +427% | +$14.2M | ﹤0.01% | 2055 |
|
|
2022
Q4 | $3.09M | Buy |
86,609
+7,705
| +10% | +$268K | ﹤0.01% | 1878 |
|
|
2022
Q3 | $2.67M | Buy |
78,904
+6,284
| +9% | +$204K | ﹤0.01% | 1904 |
|
|
2022
Q2 | $2.1M | Buy |
72,620
+976
| +1% | +$28K | ﹤0.01% | 2072 |
|
|
2022
Q1 | $2.32M | Buy |
71,644
+3,315
| +5% | +$102K | ﹤0.01% | 2106 |
|
|
2021
Q4 | $1.99M | Buy |
68,329
+13,456
| +25% | +$408K | ﹤0.01% | 2185 |
|
|
2021
Q3 | $1.46M | Buy |
54,873
+6,099
| +13% | +$164K | ﹤0.01% | 2304 |
|
|
2021
Q2 | $1.5M | Buy |
48,774
+9,778
| +25% | +$300K | ﹤0.01% | 2253 |
|
|
2021
Q1 | $1.02M | Buy |
38,996
+25,143
| +181% | +$703K | ﹤0.01% | 2390 |
|
|
2020
Q4 | $349K | Buy |
13,853
+4,071
| +42% | +$87.6K | ﹤0.01% | 2854 |
|
|
2020
Q3 | $204K | Sell |
9,782
-741
| -7% | -$16.8K | ﹤0.01% | 2914 |
|
|
2020
Q2 | $250K | Sell |
10,523
-573
| -5% | -$12.7K | ﹤0.01% | 2775 |
|
|
2020
Q1 | $200K | Sell |
11,096
-5,230
| -32% | -$110K | ﹤0.01% | 2732 |
|
|
2019
Q4 | $387K | Sell |
16,326
-10,908
| -40% | -$265K | ﹤0.01% | 2622 |
|
|
2019
Q3 | $748K | Sell |
27,234
-10,868
| -29% | -$322K | ﹤0.01% | 2136 |
|
|
2019
Q2 | $1.26M | Sell |
38,102
-542
| -1% | -$18.6K | ﹤0.01% | 1798 |
|
|
2019
Q1 | $1.35M | Buy |
38,644
+920
| +2% | +$34.2K | ﹤0.01% | 1700 |
|
|
2018
Q4 | $1.25M | Buy |
+37,724
| New | +$1.62M | ﹤0.01% | 1593 |
|
|
2018
Q3 | – | Sell |
-15,406
| Closed | -$922K | – | 2447 |
|
|
2018
Q2 | $922K | Sell |
15,406
-806
| -5% | -$41.8K | ﹤0.01% | 1085 |
|
|
2018
Q1 | $743K | Sell |
16,212
-52,387
| -76% | -$2.19M | ﹤0.01% | 1050 |
|
|
2017
Q4 | $2.73M | Buy |
68,599
+1,964
| +3% | +$77.6K | 0.01% | 823 |
|
|
2017
Q3 | $2.67M | Sell |
66,635
-3,942
| -6% | -$171K | 0.01% | 784 |
|
|
2017
Q2 | $3.04M | Buy |
70,577
+44,566
| +171% | +$1.59M | 0.01% | 767 |
|
|
2017
Q1 | $813K | Sell |
26,011
-865
| -3% | -$23.2K | ﹤0.01% | 1307 |
|
|
2016
Q4 | $678K | Sell |
26,876
-2,351
| -8% | -$52.5K | ﹤0.01% | 1358 |
|
|
2016
Q3 | $723K | Sell |
29,227
-8,454
| -22% | -$191K | ﹤0.01% | 1390 |
|
|
2016
Q2 | $768K | Sell |
37,681
-1,737
| -4% | -$30.8K | ﹤0.01% | 1452 |
|
|
2016
Q1 | $601K | Buy |
39,418
+18,320
| +87% | +$239K | ﹤0.01% | 1553 |
|
|
2015
Q4 | $284K | Buy |
21,098
+2,084
| +11% | +$32.2K | ﹤0.01% | 1861 |
|
|
2015
Q3 | $267K | Buy |
19,014
+7,158
| +60% | +$133K | ﹤0.01% | 1891 |
|
|
2015
Q2 | $201K | Buy |
+11,856
| New | +$169K | ﹤0.01% | 2135 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC
